Background
Regardless of whether cancers arise as a consequence of genetic or epigenetic changes, the factors that control the balance between replicative senescence and cancerous self-renewal are of much interest as potential therapeutic targets. However, the molecular mechanisms that regulate this perfect balance are not well understood.
Materials and methods
To better study this regulatory mechanism, we have developed a model system in vitro which allows for increase in TERT levels leading to increased proliferative potential of the cells and increased time to senescence, while at the same time the cells remain non-tumorigenic when injected into SCID mice [1] . This novel phenotype is also accompanied by induction of regeneration competence as demonstrated by significant reduction of collagen deposition in a mouse skeletal wound [2] , leading us to coin the term induced regeneration competent (iRC) cells. Understanding the mechanism of cell plasticity in the context of a defined environment will offer molecular tools for designing of regenerative instead of symptomatic treatment strategies.
Results
Our preliminary data shows an almost 14 fold transcriptional increase in PRMT8 in iRC cells displaying nuclear localization. Since PRMT8's debut in 2005, little has been published about the function of this enzyme. However, a variety of biological roles for PRMT family members are being uncovered indicating potential regulatory mechanisms for arginine methylation in cellular senescence.
Conclusions
Because of the above, we hypothesize that PRMT8 is involved in increased proliferation of iRC cells by direct or indirect regulation of TERT expression and elucidation of this pathway will uncover therapeutic targets for regenerative medicine and cancer research.
